Literature DB >> 17004022

Bacterial meningitis associated with infliximab.

Raymond Farah1, Svetlana Lisitsin, Moshe Shay.   

Abstract

We report an episode of bacterial meningitis in a 45 year-old woman, who was treated with infliximab for Wegener's granulomatosis. This patient presented with the classic clinical presentation of acute meningitis: the triad of fever, neck stiffness, and an altered mental state that appeared 6 months after the infliximab initiation. A computed tomographic (CT) scan of the head showed cerebral edema and Streptococcus pneumoniae was isolated from blood and CSF cultures. Prompt diagnosis and early treatment improved the outcome of this patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17004022     DOI: 10.1007/s11096-006-9022-x

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  18 in total

1.  Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.

Authors:  Julia Kleinert; Matthias Lorenz; Wolfgang Köstler; Walter Hörl; Gere Sunder-Plassmann; Afschin Soleiman
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

2.  Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum?

Authors:  Nikita Hegde; Charina Gayomali; Michael W Rich
Journal:  South Med J       Date:  2005-05       Impact factor: 0.954

3.  Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.

Authors:  Y Allanore; J Sellam; F Batteux; C Job Deslandre; B Weill; A Kahan
Journal:  Clin Exp Rheumatol       Date:  2004 Nov-Dec       Impact factor: 4.473

4.  Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

Authors:  Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeWoody; Paul Williamson; Jürgen Braun
Journal:  Arthritis Rheum       Date:  2005-02

Review 5.  Effects of infliximab treatment on rheumatoid synovial tissue.

Authors:  Paul P Tak
Journal:  J Rheumatol Suppl       Date:  2005-03

Review 6.  New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease.

Authors:  William J Sandborn
Journal:  Rev Gastroenterol Disord       Date:  2005

Review 7.  Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J W J Bijlsma; M Dougados; P Emery; E C Keystone; L Klareskog; P J Mease
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis.

Authors:  John A Batsis; Michael P Phy
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 3.650

9.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage.

Authors:  J Saklatvala
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

View more
  3 in total

Review 1.  What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

Authors:  Gianluca Andrisani; Alessandro Armuzzi; Manuela Marzo; Carla Felice; Daniela Pugliese; Alfredo Papa; Luisa Guidi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

2.  Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker.

Authors:  Christian Renaud; Philippe Ovetchkine; Patricia Bortolozzi; Claire Saint-Cyr; Bruce Tapiero
Journal:  Eur J Pediatr       Date:  2010-11-10       Impact factor: 3.183

3.  Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample.

Authors:  Derrick J Stobaugh; Parakkal Deepak; Eli D Ehrenpreis
Journal:  Clin Exp Gastroenterol       Date:  2013-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.